Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 77775 · Class II · American National Red Cross (The) - North Central Region
Key facts
| Event ID | 77775 |
|---|---|
| Recall numbers | B-0781-2017 |
| Recalling firm | American National Red Cross (The) - North Central Region |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Platelet product, for which required WBC quality control testing was not performed, was distributed. |
| Initiation date | Apr 28, 2017 |
| Report date | Aug 16, 2017 |
| Termination date | Aug 8, 2017 |
| City | Saint Paul |
| State | MN |
| Country | United States |
| FEI number | 2173038 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: